Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: The COAPT trial

Beohar, N., Ailawadi, G., Kotinkaduwa, L. N., Redfors, B., Simonato, M., Zhang, Z., Morgan, L. G., Escolar, E., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Abraham, W. T., Lindenfeld, J., Mack, M. J., & Stone, G. W. (2022). Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. European Heart Journal, 43(17), 1639–1648. https://doi.org/10.1093/eurheartj/ehac026
Authors:
Nirat Beohar
Gorav Ailawadi
Lak N Kotinkaduwa
Björn Redfors
Matheus Simonato
Zixuan Zhang
Loren Garrison Morgan
Esteban Escolar
Saibal Kar
David Scott Lim
Jacob M Mishell
Brian K Whisenant
William T Abraham
Joann Lindenfeld
Michael J Mack
Gregg W Stone
Affiliated Authors:
Nirat Beohar
Björn Redfors
Esteban Escolar
Columbia Affiliation:
Subjects:
Heart Failure (MeSH)
Heart Valve Prosthesis Implantation (MeSH)
Kidney Failure, Chronic (MeSH)
Mitral Valve Insufficiency (MeSH)
Author Keywords:
end-stage renal disease
guideline-directed medical therapy
mitraclip
renal dysfunction
renal replacement therapy
transcatheter mitral valve repair
elink
Publication Type:
Article
Unique ID:
10.1093/eurheartj/ehac026
DOI:
10.1093/eurheartj/ehac026
Journal:
European Heart Journal
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: